Yogev Peri, Nancy Agmon-Levin, Emanuel Theodor, Yehuda Shoenfeld
The Zabludowicz Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.
Best practice & research. Clinical rheumatology 2012 FebSjögren's syndrome is a chronic autoimmune disease characterised by progressive injury to exocrine glands accompanied by diverse extra-glandular manifestations. The spectrum of Sjögren's manifestations expanded in recent years to include new symptoms and signs such as small fibre neuropathy, and also well-defined activity and prognostic indexes. Similar to other non-organ-specific autoimmune diseases, a mosaic of factors have been linked with the development and appearances of Sjögren's syndrome. Progress has been made unravelling those factors, including susceptibility genes, immunological parameters and various environmental factors in the last decade, some of which may enable targeted therapies, biological and non-biological ones, for patients suffering from this disease. Thus, herein we review the postulated aetiologies, pathogenesis and new insights related to Sjögren's syndrome. © 2012 Elsevier Ltd. All rights reserved.
Yogev Peri, Nancy Agmon-Levin, Emanuel Theodor, Yehuda Shoenfeld. Sjögren's syndrome, the old and the new. Best practice & research. Clinical rheumatology. 2012 Feb;26(1):105-17
PMID: 22424197
View Full Text